Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal coating stent

A drug coating and drug technology, applied in coating, medical science, surgery, etc., can solve problems such as thrombosis, atherosclerosis, and unstable blood flow

Inactive Publication Date: 2012-07-18
BEIHANG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The reason is, on the one hand: the blood flow at the bifurcation of the blood vessel is unstable, and the mechanical environment at the bifurcation of the blood vessel after the stent is implanted is very complicated, which is easy to induce atherosclerosis, thrombosis, plaque and other lesions
On the other hand, the stent implantation and positioning at the vascular bifurcation are also more difficult than the single vascular stent implantation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal coating stent
  • Medicinal coating stent
  • Medicinal coating stent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0015] specific implementation plan

[0016] Specific embodiments of the present invention are described as follows:

[0017] Such as figure 1 As shown, the drug-coated stent 1 disclosed in the present invention has the shape of a vascular stent, which is composed of two parts: a stent part and a drug-coated part. The stent part can be a metal stent or a degradable stent, and its weaving method or shape can adopt the weaving method or shape of the previously disclosed vascular stent. The drug coating part is composed of two parts: polymer and drug component. The polymer can be the disclosed polymer component on the surface of the drug-coated stent, and the drug component is one of statins, rapamycins, paclitaxel, heparin or a combination of 2-4. The stent has a portion 2 where the drug concentration is uniform and higher than other parts, and the length of this portion is greater than 0 and less than the total length of the drug-coated stent 1 . In specific use, the vascul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Interventional therapy at the bifurcation of blood vessels is a difficult point in clinic, and particularly stents in the bifurcated blood vessels are difficult to introduce, and the restenosis rate is high in the later period due to high possibility of pathological changes such as thrombus, intimal hyperplasia and the like. Aiming at the problem, the invention provides a design scheme of the medicinal coating stent. In the design scheme, a section of part of which has the medicinal concentration is uniform and is higher than that of other parts is positioned in the stent; and the part with the high medicinal concentration corresponds to inlets of the bifurcated blood vessels, so that medicinal ingredients act on the bifurcated blood vessels, excessive medicinal ingredients can be applied in main blood vessels, the probability of the pathological changes such as thrombus, intimal hyperplasia and the like in the bifurcated blood vessels is reduced, and the operation of implanting the stent in the bifurcated blood vessels independently is avoided.

Description

technical field [0001] The invention relates to a drug-coated stent, in particular to a drug-coated stent for blood vessel bifurcations. Background technique [0002] At present, the main problem faced by interventional treatment of coronary artery stents is the problem of late in-stent restenosis, especially in-stent restenosis at the coronary bifurcation. There are about 1 million patients treated with percutaneous coronary intervention (PCI) every year in the world, and interventional treatment of coronary bifurcation lesions accounts for about 20% of the total number of PCIs, while the incidence of in-stent restenosis is as high as 30%. . The reason is, on the one hand: the blood flow at the bifurcation of the blood vessel is unstable, and the mechanical environment at the bifurcation of the blood vessel after the stent is implanted is very complicated, which easily induces atherosclerosis, thrombosis and plaque and other lesions. On the other hand, the implantation an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61L31/10A61L31/16
Inventor 孙安强邓小燕樊瑜波王振泽占帆刘肖
Owner BEIHANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products